G-Protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands

Journal of Hypertension

Volumn 26, Issue 5, 2008, Pages 1025-1032

  Yoro Sy, Guata ^a   Urosevic, Dragan ^a   Fellmann, Lyne ^a   Greney, Hugues ^a   Bousquet, Pascal ^a,b   Feldman, Josiane ^a  

^a INSERM   (France)

^b Lab d'Ethologie et de Neurobiologie   (France)

Author keywords

Antihypertensive agents; Arterial pressure; Central nervous system; Potassium channels; Rabbits; Signal transduction; Sympathetic nervous system

Indexed keywords

FLUPIRTINE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE RECEPTOR; LIGAND; TERTIAPIN Q; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CELL STRAIN; CHANNEL GATING; CONTROLLED STUDY; DRUG BINDING SITE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY;

EID: 42049102822     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f5ed44     Document Type: Article

References (38)

1. Bousquet P, Feldman J. Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection. Drugs 1999; 58:799-812.
2. Sun MK. Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 1995; 47:157-233.
3. McCall RB. Neurotransmitters involved in the central regulation of the cardiovascular system. Prog Drug Res 1996; 46:43-113.
4. Dampney RA, Goodchild AK, Robertson LG, Montgomery W. Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study. Brain Res 1982; 249:223-235.
5. Ross CA, Ruggiero DA, Reis DJ. Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neurol 1985; 242:511-534.
6. De Jong W, Nijkamp FP. Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat. Br J Pharmacol 1976; 58:593-598.
7. Louis WJ, Conway E, Summers R, Beart P, Jarrott B. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain. Hypertension 1984; 6 (5 Pt 2):II40-II44.
8. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
9. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha-adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984; 230:232-236.
10. Bousquet P, Feldman J, Bloch R, Schwartz J. The nucleus reticularis lateralis: a region highly sensitive to clonidine. Eur J Pharmacol 1981; 69:389-392.
11. Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience 2005; 132:991-1007.
12. Feldman J, Tibirica E, Bricca G, Dontenwill M, Belcourt A, Bousquet P. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br J Pharmacol 1990; 100:600-604.
13. Bruban V, Estato V, Schann S, Ehrhardt JD, Monassier L, Renard P, et al. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation. Circulation 2002; 105:1116-1121.
14. 1 imidazoline receptor selective ligand with hypotensive activity. J Med Chem 2001; 44:1588-1593.
15. Heemskerk FM, Dontenwill M, Greney H, Vonthron C, Bousquet P. Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem. J Neurochem 1998; 71:2193-2202.
16. Greney H, Ronde P, Magnier C, Maranca F, Rascente C, Quaglia W, et al. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline. Mol Pharmacol 2000; 57:1142-1151.
17. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch Pharmacol 1993; 348:70-76.
18. 1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther 1996; 279:694-702.
19. 1- imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol Pharmacol 1996; 49:668-675.
20. + channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain. Biochem Biophys Res Commun 1995; 208:1166-1173.
21. Jaen C, Doupnik CA. Neuronal Kir3.1/Kir3.2a channels coupled to serotonin 1A and muscarinic m2 receptors are differentially modulated by the 'short' RGS3 isoform. Neuropharmacology 2005; 49:465-476.
22. + channel currents. J Biol Chem 2001; 276:47512-47517.
23. + channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively. Neuropharmacology 1998; 37:983-987.
24. Rossi P, Mapelli L, Roggeri L, Gall D, de Kerchove d'Exaerde A, Schiffmann SN, et al. Inhibition of constitutive inward rectifier currents in cerebellar granule cells by pharmacological and synaptic activation of GABA receptors. Eur J Neurosci 2006; 24:419-432.
25. Jakob R, Krieglstein J. Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones. Br J Pharmacol 1997; 122:1333-1338.
26. + channels. Biochemistry 1998; 37:13291-13299.
27. 1 imidazoline receptors. Mol Pharmacol 2002; 62:181-191.
28. Jeon YT, Luo C, Fooray C, Vaysse PJ-J, Branchek TA, Gluchowski C. Pharmacological evaluation of UK-14,304 analogs at cloned human alphaadrenergic receptors. Bioorg Med Chem Lett 1995; 5:2255-2258.
29. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-3108.
30. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:220-239.
31. 2+ block via activation of voltage independent potassium channels. Rapid communication. J Neural Transm 1999; 106:857-867.
32. Felix JP, Liu J, Schmalhofer WA, Bailey T, Bednarek MA, Kinkel S, et al. Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapin. Biochemistry 2006; 45:10129-10139.
33. Chan CK, Burke SL, Head GA. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. J Hypertens 2007; 25:147-155.
34. Mayorov DN, Burke SL, Head GA. Relative importance of rostral ventrolateral medulla in sympathoinhibitory action of rilmenidine in conscious and anesthetized rabbits. J Cardiovasc Pharmacol 2001; 37:252-261.
35. Sannajust F, Cerutti C, Koenig-Berard E, Sassard J. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol 1992; 105:542-548.
36. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol Rev 2003; 55:575-578.
37. Yamakage M, Namiki A. Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review. Can J Anaesth 2002; 49:151-164.
38. Waterhouse RN. Imaging the PCP site of the NMDA ion channel. Nucl Med Biol 2003; 30:869-878.